S100A9 and hepatocellular carcinoma: In hepatocellular carcinoma and sepsis-induced cardiomyopathy, S100A9 exacerbates the disease by promoting mitochondrial fission through the deubiquitination of PGAM5 or the activation of ERK1/2-DRP1, respectively35, 36.